Presentation of an affected family with tuberous sclerosis
Keywords:
Esclerosis tuberosa, enfermedad de Pringle Bourneville, manchas hipomelánicas y convulsionesAbstract
Introduction: tuberous sclerosis is a genetic disease with clinical heterogeneity, an autosomal dominant inheritance pattern, variable expressivity and caused in more than 75 % by de novo mutations. It is clinically characterized by hamartomatous lesions, hypochromic spots on the skin, facial and uncal angiofibromas and frequently associated with alterations in the central nervous system. Objective: to describe the great clinical heterogeneity with which this disease occurred in a family. Methods: the clinical pattern method was used and was reviewed the updated literature. Informed consent was requested to take photos in order to compare them with similar cases and to consult with experts, as well as, to publish them in scientific journals.Clinical case: a nuclear family is presented. The female has hamartomatous lesions on the face and at the age of 30 years she was diagnosed with renal angiolipoma and the disease was suspected when her children were evaluated in consultation. A 7-year-old girl was born with hypochromic spots and began to have seizures at the age of 3, diagnosed as difficult-to-control epilepsy and a 2-year-old boy, with several large facial sebaceous adenomas, in addition to numerous hypochromic lesions; it was then that the clinical diagnosis of tuberous sclerosis was made in these patients. Conclusions: variable expressivity and clinical heterogeneity are considered to be phenomena that make the clinical diagnosis of this disease difficult, as have happened with this family, therefore, the clinical method is very useful to correctly delineate the phenotype and provide adequate genetic counseling.
Downloads
References
1. Portocarrero LKL, Quental KN, Samorano LP, Oliveira ZNP, Rivitti-Machado MCDM. Tuberous sclerosis complex: review based on new diagnostic criteria. An Bras Dermatol. 2018 Jun;[citado 31/01/24]93(3):323-331. doi: 10.1590/abd1806-4841.20186972. PMID: 29924239; PMCID: PMC6001077.
2. Islam MP. Tuberous Sclerosis Complex. Semin Pediatr Neurol. 2021 Apr;[citado 11/01/24]37:100875. doi: 10.1016/j.spen.2021.100875. Epub 2021 Feb 11. PMID: 33892851.
3. Vázquez-Lavista LG, Ramírez-Muciño JA, López-Almanza PX, Janka-Zires M. Tuberous Sclerosis Complex. Urology. 2022 Feb;[citado 18/01/24]160:19-21. doi: 10.1016/j.urology.2021.10.024. Epub 2021 Nov 6. PMID: 34752847.
4. Pfirmann P, Combe C, Rigothier C. Sclérose tubéreuse de Bourneville : mise au point [Tuberous sclerosis complex: A review]. Rev Med Interne. 2021 Oct[citado 1/02/24];42(10):714-721. French. doi: 10.1016/j.revmed.2021.03.003. Epub 2021 Apr 6. PMID: 33836894.
5. Zhang LW, Chen T. Tuberous Sclerosis Complex. J Cutan Med Surg. 2023 Nov;[citado 31/01/24]27(6):674. doi: 10.1177/12034754231174851. Epub 2023 May 17.PMID: 37195068.
6. Bissler JJ, Batchelor D, Kingswood JC. Progress in Tuberous Sclerosis Complex Renal Disease. Crit Rev Oncog. 2022;[citado 11/01/24]27(2):35-49. doi: 10.1615/CritRevOncog.2022042857. PMID: 36734871.
7. Van Bogaert P, Nabbout R. Updating Tuberous sclerosis complex care for pediatric neurologists. Arch Pediatr. 2022 Dec;[citado 11/01/24]29(5S):5S1-5S2. doi: 10.1016/S0929-693X(22)00282-2. PMID: 36585065.
8. Almutairi A, Hundallah K. Tuberous sclerosis. Neurosciences (Riyadh). 2019 Oct;[citado 30/01/24]24(4):335-337. doi: 10.17712/nsj.2019.4.20190107. PMID: 31872817; PMCID: PMC8015558.
9. Volpi A, Sala G, Lesma E, Labriola F, Righetti M, Alfano RM, Cozzolino M. Tuberous sclerosis complex: new insights into clinical and therapeutic approach. J Nephrol. 2019 Jun;32(3):[citado 1/02/24]355-363. doi: 10.1007/s40620-018-0547-6. Epub 2018 Nov 7. PMID: 30406604.
10. Notaro K, Pierce B. Tuberous sclerosis complex: A multisystem disorder. JAAPA. 2021 Mar 1;[citado 31/01/24]34(3):28-33. doi: 10.1097/01.JAA.0000733220.26720.62. PMID: 33528170.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Revista Cubana de Neurologia y Neurocirugia

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

